nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An in silico approach for identification of lead compound as FtsZ inhibitor
|
Kifayat, Sumaiya |
|
|
28 |
6 |
p. 3937-3948 |
artikel |
2 |
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
|
Sabt, Ahmed |
|
|
28 |
6 |
p. 4581-4608 |
artikel |
3 |
Anticancer activity features of imidazole-based ionic liquids and lysosomotropic detergents: in silico and in vitro studies
|
Gryniukova, Anastasiia |
|
|
28 |
6 |
p. 3817-3833 |
artikel |
4 |
Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021–2023)
|
Sharma, Anchal |
|
|
28 |
6 |
p. 4609-4633 |
artikel |
5 |
Biocomputational screening of natural compounds targeting 15-hydroxyprostaglandin dehydrogenase to improve skeletal muscle during aging
|
Ahmad, Syed Sayeed |
|
|
28 |
6 |
p. 4425-4439 |
artikel |
6 |
Clustering of atoms relative to vector space in the Z-matrix coordinate system and ‘graphical fingerprint’ analysis of 3D pharmacophore structure
|
Kızılcan, Dilek Şeyma |
|
|
28 |
6 |
p. 4087-4104 |
artikel |
7 |
Comprehensive computational investigation for ligand recognition and binding dynamics of SdiA: a degenerate LuxR -type receptor in Klebsiella pneumoniae
|
Panchal, Janki |
|
|
28 |
6 |
p. 3897-3918 |
artikel |
8 |
Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy
|
Gopal, Dhanushya |
|
|
28 |
6 |
p. 4343-4359 |
artikel |
9 |
Copper (II) complex supported on magnetic nanoparticles as a novel nanocatalyst for the synthesis of imidazo[1,2-a]pyridines
|
Jiang, Shanshan |
|
|
28 |
6 |
p. 3859-3877 |
artikel |
10 |
Deciphering neuroprotective mechanism of nitroxoline in cerebral ischemia: network pharmacology and molecular modeling-based investigations
|
Vadak, Namrata |
|
|
28 |
6 |
p. 3993-4015 |
artikel |
11 |
Deciphering the multi-functional role of Indian propolis for the management of Alzheimer’s disease by integrating LC–MS/MS, network pharmacology, molecular docking, and in-vitro studies
|
Sankaran, Sandeep |
|
|
28 |
6 |
p. 4325-4342 |
artikel |
12 |
Design and investigation of interactions of novel peptide conjugates of purine and pyrimidine derivatives with EGFR and its mutant T790M/L858R: an in silico and laboratory study
|
Hunt, Hannah L. |
|
|
28 |
6 |
p. 3683-3711 |
artikel |
13 |
Design, synthesis and biological evaluation of MNK-PROTACs
|
Sun, Xue |
|
|
28 |
6 |
p. 3783-3800 |
artikel |
14 |
Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors
|
Salarinejad, Somayeh |
|
|
28 |
6 |
p. 4167-4180 |
artikel |
15 |
Design, synthesis, and pharmacological evaluation of indazole carboxamides of N-substituted pyrrole derivatives as soybean lipoxygenase inhibitors
|
Lavrentaki, Vasiliki |
|
|
28 |
6 |
p. 3757-3782 |
artikel |
16 |
Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation
|
Kanchrana, Madhu |
|
|
28 |
6 |
p. 3979-3991 |
artikel |
17 |
Discovery of novel Akt1 inhibitors by an ensemble-based virtual screening method, molecular dynamics simulation, and in vitro biological activity testing
|
Zhang, Wen |
|
|
28 |
6 |
p. 3949-3963 |
artikel |
18 |
Discovery of Palbociclib as a potent c-Myc G4 stabilizer for lung cancer treatment using molecular docking, molecular dynamics simulation, and in vitro activity evaluation
|
Gao, Jian |
|
|
28 |
6 |
p. 3965-3977 |
artikel |
19 |
Diversifying the benzenesulfonamide scaffold for potential V-ATPase inhibitors: synthesis and insecticidal activity evaluation
|
Qian, Hao |
|
|
28 |
6 |
p. 4105-4111 |
artikel |
20 |
Exploring host epigenetic enzymes as targeted therapies for visceral leishmaniasis: in silico design and in vitro efficacy of KDM6B and ASH1L inhibitors
|
Dutta, Mukul |
|
|
28 |
6 |
p. 4403-4424 |
artikel |
21 |
First report on chemometrics-driven multilayered lead prioritization in addressing oxysterol-mediated overexpression of G protein-coupled receptor 183
|
Bhattacharjee, Arnab |
|
|
28 |
6 |
p. 4199-4220 |
artikel |
22 |
Fluorinated 2-arylchroman-4-ones and their derivatives: synthesis, structure and antiviral activity
|
Troshkova, Nadezhda |
|
|
28 |
6 |
p. 3635-3660 |
artikel |
23 |
Green synthesis and investigation of antioxidant and antibacterial activity of new derivatives of chromenoazepines employing CuO/TiO2@MWCNTs
|
Hasani, Leila |
|
|
28 |
6 |
p. 4137-4149 |
artikel |
24 |
Guanidine dicycloamine-based analogs: green chemistry synthesis, biological investigation, and molecular docking studies as promising antibacterial and antiglycation leads
|
El-Remaily, Mahmoud Abd El Aleem. A. A. |
|
|
28 |
6 |
p. 4277-4299 |
artikel |
25 |
Identification of molecular targets of Trigonelline for treating breast cancer through network pharmacology and bioinformatics-based prediction
|
Manivannan, Hema Priya |
|
|
28 |
6 |
p. 3835-3857 |
artikel |
26 |
Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of Alzheimer’s disease
|
Jangra, Jatin |
|
|
28 |
6 |
p. 4381-4401 |
artikel |
27 |
Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer’s disease
|
Devi, Bharti |
|
|
28 |
6 |
p. 4361-4380 |
artikel |
28 |
In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer
|
Kumar, Sunil |
|
|
28 |
6 |
p. 4301-4324 |
artikel |
29 |
In silico identification of potential phytochemical inhibitors for mpox virus: molecular docking, MD simulation, and ADMET studies
|
Ghate, Sudeep D. |
|
|
28 |
6 |
p. 4067-4086 |
artikel |
30 |
Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes
|
Banat, Rajaa |
|
|
28 |
6 |
p. 4241-4257 |
artikel |
31 |
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship
|
Maji, Lalmohan |
|
|
28 |
6 |
p. 4467-4513 |
artikel |
32 |
Multi-method computational evaluation of the inhibitors against leucine-rich repeat kinase 2 G2019S mutant for Parkinson's disease
|
Elhadi, Ahmed |
|
|
28 |
6 |
p. 4181-4197 |
artikel |
33 |
Network-based drug repurposing identifies small molecule drugs as immune checkpoint inhibitors for endometrial cancer
|
Ahmed, Faheem |
|
|
28 |
6 |
p. 3879-3895 |
artikel |
34 |
Novel flavonol derivatives containing benzoxazole as potential antiviral agents: design, synthesis, and biological evaluation
|
Zhou, Yuanxiang |
|
|
28 |
6 |
p. 3919-3935 |
artikel |
35 |
Organohalogen chalcones: design, synthesis, ADMET prediction, molecular dynamics study and inhibition effect on acetylcholinesterase and carbonic anhydrase
|
Aydin, Busra Ozturk |
|
|
28 |
6 |
p. 3739-3755 |
artikel |
36 |
Precision in stereochemistry: the integral role of catalytic asymmetric Biginelli reaction in crafting enantiomerically pure dihydropyrimidinones
|
Bendi, Anjaneyulu |
|
|
28 |
6 |
p. 4441-4466 |
artikel |
37 |
Repositioning of anti-infective compounds against monkeypox virus core cysteine proteinase: a molecular dynamics study
|
Rabaan, Ali A. |
|
|
28 |
6 |
p. 4113-4135 |
artikel |
38 |
Screening inhibitors against the Ef-Tu of Fusobacterium nucleatum: a docking, ADMET and PBPK assessment study
|
Alzamami, Ahmad |
|
|
28 |
6 |
p. 4259-4276 |
artikel |
39 |
Structure-based drug design and characterization of novel pyrazine hydrazinylidene derivatives with a benzenesulfonate scaffold as noncovalent inhibitors of DprE1 tor tuberculosis treatment
|
Shivakumar, |
|
|
28 |
6 |
p. 4221-4239 |
artikel |
40 |
Structure-based virtual screening against multiple Plasmodium falciparum kinases reveals antimalarial compounds
|
Godara, Priya |
|
|
28 |
6 |
p. 3661-3681 |
artikel |
41 |
Sulfonamido, amido heterocyclic adducts of tetrazole derivatives as BACE1 inhibitors: in silico exploration
|
Joshi, Nachiket |
|
|
28 |
6 |
p. 4017-4049 |
artikel |
42 |
Synthesis, biological activities and mechanism studies of 1,3,4-oxadiazole analogues of petiolide A as anticancer agents
|
Zhang, Minjie |
|
|
28 |
6 |
p. 3713-3737 |
artikel |
43 |
Synthesis, biological evaluation and molecular docking studies of novel 1,3,4-thiadiazoles as potential anticancer agents and human carbonic anhydrase inhibitors
|
Karakuş, Sevgi |
|
|
28 |
6 |
p. 3801-3815 |
artikel |
44 |
Synthesis, modifications, and applications of iron-based nanoparticles
|
Shahbazi, Raheleh |
|
|
28 |
6 |
p. 4515-4552 |
artikel |
45 |
Synthesis of propargylamine: pioneering a green path with non-conventional KA2 coupling approach
|
Khadanga, Lambodar |
|
|
28 |
6 |
p. 4635-4650 |
artikel |
46 |
Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor
|
Zia, Komal |
|
|
28 |
6 |
p. 4151-4165 |
artikel |
47 |
The identification of c-Abl inhibitors as potential agents for Parkinson’s disease: a preliminary in silico approach
|
Rymbai, Emdormi |
|
|
28 |
6 |
p. 4051-4065 |
artikel |
48 |
Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement
|
Lalhmangaihzuala, Samson |
|
|
28 |
6 |
p. 4553-4579 |
artikel |